Metformin treats polycystic ovarian syndrome by improving insulin sensitivity
the verdict
SUPPORTED
the evidence backs this
confidence 77/100
Metformin is widely recognized as a standard treatment for polycystic ovary syndrome (PCOS) because it targets and improves underlying insulin resistance and metabolic dysfunction.
Evidence for · 5
Natural Products in the Metabolic and Endocrine Modulation of Polycystic Ovary Syndrome: Current Perspectives.
2026 · cited by 1
Paper 0 highlights that insulin sensitizers like metformin are standard pharmacological treatments used to address underlying insulin resistance in polycystic ovary syndrome.
See more details
More for · 4
Hypothalamic Inflammation as a Critical Link Between Metabolic Dysfunction and Impaired Endometrial Receptivity in Obese Polycystic Ovary Syndrome.
2026 · cited by 0
Paper 2 demonstrates that metformin improves insulin resistance and metabolic parameters in animal models of polycystic ovary syndrome.
Possible protective effects of tirzepatide on polycystic ovary syndrome in female rat model induced by testosterone propionate in comparison to metformin.
2026 · cited by 0
Paper 4 notes that traditional metformin therapy improves insulin sensitivity in polycystic ovary syndrome.
Polycystic ovary syndrome and insulin resistance: A focus on pathogenesis, risk factors, and therapeutic strategies.
2026 · cited by 0
Paper 5 confirms that conventional therapeutic approaches for polycystic ovary syndrome focus on improving insulin sensitivity using agents such as metformin.
Metformin improves endotoxemia and alters folliculogenesis in women with polycystic ovary syndrome.
2026 · cited by 0
Paper 7 notes that metformin is frequently used in polycystic ovary syndrome treatment specifically to improve glucose metabolism and insulin levels.